Cargando…

Real-Time Monitoring Platform for Ocular Drug Delivery

Real-time measurement is important in modern dissolution testing to aid in parallel drug characterisation and quality control (QC). The development of a real-time monitoring platform (microfluidic system, a novel eye movement platform with temperature sensors and accelerometers and a concentration p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Awwad, Sahar, Ibeanu, Nkiruka, Liu, Tianyang, Velentza-Almpani, Angeliki, Chouhan, Nerisha, Vlatakis, Stavros, Khaw, Peng Tee, Brocchini, Steve, Bouremel, Yann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220597/ https://www.ncbi.nlm.nih.gov/pubmed/37242686 http://dx.doi.org/10.3390/pharmaceutics15051444

Ejemplares similares

Effects of Flow Hydrodynamics and Eye Movements on Intraocular Drug Clearance
por: Velentza-Almpani, Angeliki, et al.
Publicado: (2022)

Hydrodynamics of Intravitreal Injections into Liquid Vitreous Substitutes
por: Henein, Christin, et al.
Publicado: (2019)

Injectables and Depots to Prolong Drug Action of Proteins and Peptides
por: Ibeanu, Nkiruka, et al.
Publicado: (2020)

Author Response: Ab Interno versus Ab Externo Surgical Approach on Outflow Resistance of a Subconjunctival Drainage Device
por: Lee, Richard M. H., et al.
Publicado: (2020)

The Implications of an Ab Interno Versus Ab Externo Surgical Approach on Outflow Resistance of a Subconjunctival Drainage Device for Intraocular Pressure Control
por: Lee, Richard M. H., et al.
Publicado: (2019)

Translating Minimally Invasive Glaucoma Surgery Devices
por: Lee, Richard M.H., et al.
Publicado: (2019)

Novel approaches to model effects of subconjunctival blebs on flow pressure to improve clinical grading systems after glaucoma drainage surgery
por: Bouremel, Yann, et al.
Publicado: (2019)

3D Printed Punctal Plugs for Controlled Ocular Drug Delivery
por: Xu, Xiaoyan, et al.
Publicado: (2021)

Development of Targeted siRNA Nanocomplexes to Prevent Fibrosis in Experimental Glaucoma Filtration Surgery
por: Fernando, Owen, et al.
Publicado: (2018)

An anti-TNF-α antibody mimetic to treat ocular inflammation
por: Khalili, Hanieh, et al.
Publicado: (2016)

An Ilomastat-CD Eye Drop Formulation to Treat Ocular Scarring
por: Mohamed-Ahmed, Abeer H. A., et al.
Publicado: (2017)

Comparative thermodynamic analysis in solution of a next generation antibody mimetic to VEGF
por: Khalili, Hanieh, et al.
Publicado: (2018)

Personalized Medicine in Ocular Fibrosis: Myth or Future Biomarkers
por: Yu-Wai-Man, Cynthia, et al.
Publicado: (2016)

Overview of Antibody Drug Delivery
por: Awwad, Sahar, et al.
Publicado: (2018)

Recent Advances in the Excipients Used for Modified Ocular Drug Delivery
por: Koutsoviti, Melitini, et al.
Publicado: (2021)

Impact of Peptide Structure on Colonic Stability and Tissue Permeability
por: Taherali, Farhan, et al.
Publicado: (2023)

Discovery and Potential Utility of a Novel Non-Invasive Ocular Delivery Platform
por: Wang, Weizhen (Jenny), et al.
Publicado: (2023)

Selective vulnerability in α-synucleinopathies
por: Alegre-Abarrategui, Javier, et al.
Publicado: (2019)

Neuroprotective Nanoparticles Targeting the Retina: A Polymeric Platform for Ocular Drug Delivery Applications
por: Colucci, Patrizia, et al.
Publicado: (2023)

Tau-proximity ligation assay reveals extensive previously undetected pathology prior to neurofibrillary tangles in preclinical Alzheimer’s disease
por: Bengoa-Vergniory, Nora, et al.
Publicado: (2021)

Recent Progress of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Ocular Drug Delivery Platforms
por: Gugleva, Viliana, et al.
Publicado: (2023)

Topical Drug Delivery in the Treatment of Skin Wounds and Ocular Trauma Using the Platform Wound Device
por: Eriksson, Elof, et al.
Publicado: (2023)

A Review of Ocular Drug Delivery Platforms and Drugs for Infectious and Noninfectious Uveitis: The Past, Present, and Future
por: Conrady, Christopher D., et al.
Publicado: (2021)

Complications of anesthesia during electroconvulsive therapy due to undiagnosed obstructive sleep apnea: A case-study
por: Trakada, Georgia, et al.
Publicado: (2017)

Natamycin Ocular Delivery: Challenges and Advancements in Ocular Therapeutics
por: Mascarenhas, Mabel, et al.
Publicado: (2023)

A hybrid genipin-crosslinked dual-sensitive hydrogel/nanostructured lipid carrier ocular drug delivery platform
por: Yu, Yibin, et al.
Publicado: (2019)

Polysaccharides in Ocular Drug Delivery
por: Dubashynskaya, Natallia, et al.
Publicado: (2019)

The Ocular Gene Delivery Landscape
por: Sahu, Bhubanananda, et al.
Publicado: (2021)

Cluster Bomb Ocular Injuries
por: Mansour, Ahmad M., et al.
Publicado: (2012)

Maillard Reaction Crosslinked Alginate-Albumin Scaffolds for Enhanced Fenofibrate Delivery to the Retina: A Promising Strategy to Treat RPE-Related Dysfunction
por: Abedin Zadeh, Maria, et al.
Publicado: (2023)

Stable Dried Catalase Particles Prepared by Electrospraying
por: Schlosser, Corinna S., et al.
Publicado: (2022)

Nanotechnology Approaches for Ocular Drug Delivery
por: Xu, Qingguo, et al.
Publicado: (2013)

Ocular Drug Delivery for Glaucoma Management
por: Gooch, Nathan, et al.
Publicado: (2012)

Lipid Nanoparticles for Ocular Gene Delivery
por: Wang, Yuhong, et al.
Publicado: (2015)

Penetration Enhancers in Ocular Drug Delivery
por: Moiseev, Roman V., et al.
Publicado: (2019)

Advances in Ocular Drug Delivery Systems
por: Silva-Cunha, Armando
Publicado: (2021)

Ocular Drug Delivery: Advancements and Innovations
por: Tian, Bo, et al.
Publicado: (2022)

Nanoparticles in Ocular Drug Delivery Systems
por: Almeida, Hugo, et al.
Publicado: (2023)

Is preference for mHealth intervention delivery platform associated with delivery platform familiarity?
por: Granger, Daniel, et al.
Publicado: (2016)

Augmented superior rectus muscle transposition in management of defective ocular abduction
por: Farid, Mohamed F., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gq4uins3tq3hr5464u9v4f3r1o